2025年2月19日,史赛克Stryker(纽约证券交易所代码:SYK)宣布,已完成先前宣布的对Inari Medical的收购。该公司上个月宣布达成协议,以每股80美元的现金收购Inari Medical,交易总价值约为49亿美元(合约360亿人民币)。Inari Medical 是一家专注于静脉血栓栓塞症(VTE)治疗的公司,其产品包括用于治疗深静脉血栓和肺栓塞等疾病的机械血栓切除设备。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.